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Available online 14 August 2016Nodding Syndrome (NS) is an epileptic encephalopathy characterized by involuntary vertical head nodding,
other types of seizures, and progressive neurological deﬁcits. The etiology of the east African NS epidemic is un-
known. InMarch 2014, we conducted a case-control study of medical, nutritional and other risk factors associat-
ed with NS among children (aged 5–18 years) of Kitgum District, northern Uganda (Acholiland). Data on food
availability, rainfall, and prevalent disease temporally related to the NS epidemic were also analyzed. In NS
Cases, the mean age of reported head nodding onset was 7.6 years (range 1–17 years). The epidemiologic
curve of NS incidence spanned 2000–2013, with peaks in 2003 and 2008. Month of onset of head nodding was
non-uniform, with all-year-aggregated peaks in April and June when food availability was low. Families with
one or more NS Cases had been signiﬁcantly more dependent on emergency food and, immediately prior to
head nodding onset in the child, subsistence onmoldy plant materials, speciﬁcally moldy maize. Medical history
revealed a single signiﬁcant association with NS, namely prior measles infection. NS is compared with the post-
measles disorder subacute sclerosing panencephalitis, with clinical expression triggered by factors associated
with poor nutrition.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Nodding Syndrome (NS) is an idiopathic brain disorder of children
and adolescents in parts of east Africa [1]. The disorder was ﬁrst recog-
nized in Tanzania where it has been extant for decades among
impoverished residents (Wapogoro) of the Mahenge mountains [2–4].
For the past 20–25 years, epidemics of NS have occurred in conﬂictmer), Oregon Health & Science
dicine, University of California,
orado, USA.
Oregon, USA.
ts.
. This is an open access article underzones of South Sudan (among the Moru) and in northern Uganda
(Acholi) where community disruption has required emergency supplies
of food, medicine and seed for planting [5–9]. Preliminary case-control
studies led by the World Health Organization in 2002 [5,8] and the U.S
Centers for Disease Control and Prevention (CDC) in 2012 found that
South/Sudanese childrenwithNSwere small for age, stunted, reproduc-
tively undeveloped, infected with nematodes (notably Onchocerca vol-
vulus, OV, in skin but not cerebrospinal ﬂuid by PCR), dependent on
home-grown food, and had a history of infant hunger in the ﬁrst
2 years of life [1,4,10]. Several Moru families had more than one NS-af-
fected child, disease usually starting with vertical nodding (atonic sei-
zure, 10–20/min, elicited most commonly by food but also by cold) in
awake and initially responsive children, and evolving over 2–5 years
to more frequent nodding and whole-body convulsions, leading to se-
vere wasting, mental retardation, burns, stigmatization, social isolationthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ern Equatoria Province began in 1991 and peaked in 1998–2001, and af-
fected both male and female children aged 2–19 years (age 9–12
maximally), with onset between 5 and 13 years, with a peak at age 9
[5,8].
In northern Uganda (Acholiland), reports of NS began to appear in
1997 [7,9], with the ﬁrst recorded cases in Kitgum District in 1998
(Fig. 1). Cases rapidly increased annually beginning in 2001, with
peaks in 2003–2005 and 2008, 5–6 years after peaks in the number of
wartime conﬂicts and deaths. Additionally, peaks of NS followed peak
inﬂuxes 5–7 years earlier of households into internal displacement
camps [9]. The 2013 estimated number of probable Ugandan NS Cases
was 1687 (95% conﬁdence interval [CI]= 1463–1912), for a prevalence
of 6.8 (CI = 5.9–7.7) per 1000 children aged 5–18 years in the three
most heavily impacted districts of Kitgum, Lamwo and Pader [11].
Kitgum District, the location of the present study, experienced a NS ep-
idemic between 2000 and 2011 [7,9,12]. A December 2009 study in
west KitgumDistrict, led by theU.S. Centers for Disease Control and Pre-
vention (CDC), estimated a prevalence of 12 (0.6 to 46 cases) per 1000
ﬁve- to 15-year-old children [7]. Factors associated with NS in the CDC-
led case-control study included a positive OV serology, exposure to mu-
nitions (later deﬁned as ‘gun raids’), and consumption of “crushed
roots” used in traditional medicine [7]. The plant species and therapeu-
tic intent were not stated but, in Uganda, the crushed roots of
Cryptolepis sanguinolenta (Lindl.) Schltr. traditionally are used for treat-
ment of snakebites, hernia and measles [13], the latter representing a
potential link with ﬁndings reported here.
In March 2014, we conducted a case-control study to evaluate the
medical history, environmental exposures and current health of adoles-
cents with NS in Tumangu, southwest of Kitgum Town.We also investi-
gated the temporal onset of head nodding in relation to residence,
climate, harvest patterns, food availability, and infectious disease. In
contrast to the 2009 CDC-led study, we found evidence of seasonal var-
iation in NS onset and association of NS with prior acute measles infec-
tion and consumption of fungus-contaminated plant food immediately
before onset of head nodding. Preliminary ﬁndings have been reported
elsewhere [14,15].
2. Methods
2.1. Setting
The study was set in Tumangu Village, Lamit Parish, Labongo
Akwang Sub-County, Kitgum District in northern Uganda (Fig. 1). AnFig. 1. Map of Uganda showing Kitgum District; the approximate location of Tumangu
Village is marked with a spot. The capital city of Kampala (box) is ~8 h by road from
Kitgum, which abuts South Sudan.isolated, largely rural community, KitgumDistrict has high levels of pov-
erty, inadequate water and sanitation, and signiﬁcant disease burden.
Child and maternal mortality rates in 2007 were higher than in most
parts of Uganda [16]. Between 1987 and 2006/2008, this region was a
civil war zone involving the Lords Resistance Army (LRA), the Sudan
People's Liberation Army, and the Ugandan Peoples Defence Force. The
civil war resulted in human atrocities, including rape, abduction of chil-
dren, conﬁscation of livestock, killing of unarmed civilians, and destruc-
tion of granaries, schools, hospitals, and bore holes. Beginning in 1996,
Acholi civilians were moved into internally displaced peoples' (IDP)
camps where many families became dependent on emergency food
supplies. Camp lifewas associatedwithmalnutrition, social breakdown,
a rising incidence of mental health disorders and alcoholism. The camps
also became breeding grounds for cholera, measles, HIV/AIDS and other
preventable diseases. In 2008, following the expulsion of the LRA, the
Acholi people began to return to their villages and rebuild their society
[17]. After NS was recognized in Acholiland, Uganda registered affected
children, established government Screening and Treatment Centers [18]
and distributed anticonvulsants and nutritional supplementation to af-
fected children [19].
2.2. Ethics statement
Study and instrument design were approved by the Institutional Re-
view Board (IRB) of Oregon Health & Science University, Portland, Ore-
gon, USA, in concert with the Research and Ethics Committee of the
School of Health Sciences of Makerere University, Kampala, Uganda.
The university-approved research plan was reviewed and approved by
the Uganda National Council for Science and Technology, the Ofﬁce of
the President of Uganda, and the Chairman, Local Council III, Kitgum
District, northern Uganda. The research team worked closely with the
Tumangu Village Health Team Leader in carrying out the study in the
open air at a central collecting point (large mango tree) in the village.
Parents and or guardians (caregivers) of children gave informed
consent on behalf of all child participants. Informed consent for the in-
terview was administered orally and data collected by 5 Ugandan med-
ical students who spoke with household caretakers in the Acholi
language under the supervision of an academic physician (D.L.K.) who
was born and nurtured near Kitgum Town. IRB-approved oral consent
was employed because the caregivers could not read the documents.
Oral consent was documented by placement of an inked thumbprint
on the consent forms. Caretakers of children were paid for their time
the equivalent of U.S. $10.00 in local currency. One copy of the set of ex-
ecuted consent formswas depositedwith theDepartment of Food Tech-
nology and Nutrition, College of Agricultural and Environmental
Sciences, Makerere University, Kampala, Uganda.
2.3. Case-control study design
NS Cases (n = 50) and Community Controls (N = 50) were 5 to
18 years of age. NS Cases were deﬁned according to an international
consensus deﬁnition [6]. Community Controls (CC) drawn from NS-
free households in the same community had no history of head nodding
or other seizures, including febrile seizures. Randomly selected NS and
CC were individually screened and examined by the research team.
Each NS and CCwasmatched both by age (n=50pairs) and, whenever
possible, by both age and sex (n=42 pairs). In addition to the NS Cases
included in the study, data were collected for age of onset and year/
month of onset (when available) of head nodding in other children
with documented NS in households with NS Cases.
2.3.1. Study instrument
A questionnaire directed to parents or caregivers requested a listing
of family members, including those with and without NS, and the year
and month of the ﬁrst sign of head nodding in all children with NS in
the household. A detailed history of food use by the familywas obtained
Fig. 2. Semi-bimodal epidemic curve of Nodding Syndrome. For NS Cases enrolled in the
NS-CC Case-Control study (solid line; n = 50 NS), reported onset of head nodding
peaked in 2003 and 2008 (n = 7 each), though the incidence was only marginally
higher than that in 2005 and 2007 (n= 6). For NS Cases plus other household NS Cases
(dashed line; n = 83), NS onset also peaked in 2003 (n = 14) and 2008 (n = 11). In
both analyses, onset incidence began to decrease after 2008.
Fig. 3. Reported month of onset of head nodding was non-uniform, with all-year
aggregated peaks (2000−2013) that were unrelated to the monthly rainfall pattern in
Kitgum (2003−2012). For NS Cases (solid black bars) plus other household NS Cases
(patterned bar) (n = 43 + 25, respectively), reported NS-onset peaks showed a non-
uniform distribution throughout the year (χ2 = 26.131, df = 11, p b 0.01). Month of
head nodding onset was reported in the 2014 Tumangu survey questionnaire. Rainfall
data (ﬁlled circles) were collected from the Kitgum District Five Year Plan [28].
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head nodding, or for an equivalent time period for Community Controls,
including: the type of food items, quality of major food items, and the
relative dietary importance of these items. Additional survey questions
for NS and CC included birthdate of the child and prior place(s) of resi-
dence. The child's past medical history (prior diseases, history of vacci-
nation) and current health status were reported by the caregiver or
parents and described by the absence or presence of themedical condi-
tion and clinical manifestations of illness.
2.3.2. Anthropometric data
Each child was measured clothed and barefoot for height and body
weight. Weight was measured using a calibrated digital scale. Height
was measured using a vertical stadiometer.
2.3.3. Data extraction and analyses
Information was extracted from questionnaires independently by
two research team members who then compared the data for consis-
tency and resolved any inconsistencies by mutual agreement and in
consultation with the Study Director. Conditional logistic regression
was used to screen 57 potential explanatory variables (9 continuous, 3
ordinal and 45 dichotomous) for associationwithNS. p-Valueswere de-
rived from likelihood ratio (LR) tests and 95% conﬁdence intervals for
the odds ratio(s) found by inverting the LR test. Likelihood-based
methods were chosen over standard Wald tests/conﬁdence intervals
because they exhibit better performance in small sampleswhen asymp-
totic (Wald) inference may be less reliable. Formal adjustment for mul-
tiple testing was not done, as the investigation sought to identify
associations of interest rather than test a pre-speciﬁed list of targets. In-
stead, the method of Schweder and Spjøtvoll [20] was used to identify
the most promising associations in the collection of all variables
considered.
2.4. Environment, food security, and vaccine-preventable disease
Ecological analyses were performed on information drawn from
publicly available electronic records. These data included region-specif-
ic annual rainfall; ambient temperature; crop planting and harvesting
patterns; measures of food security, and emergency food supplies pro-
vided by the World Food Programme [21]. The WHO Vaccine Prevent-
able Diseases Monitoring System and data from Doctors Without
Borders sourced information on infectious disease in East Africa, notably
measles, and vaccination campaigns [22–27].
3. Results
3.1. Nodding Syndrome: year and month of onset
In addition to the 50 NS Cases, 33 other household NS cases were
identiﬁed, all of whom were reported in households with a NS case.
For both NS sets and for the total NS subjects (n=83), year of reported
onset of heading nodding spanned 2000–2013, with incidence increas-
ing markedly from 2001 and declining after 2008 (Fig. 2).
When data from 2000 to 2013 were aggregated, the mean month of
reported onset of head nodding was similar in the NS Cases (known in
43), other household children with NS (known in 25) and, therefore,
the combination of the two (Fig. 3). Combined, NS Cases and other chil-
dren with NS showed a signiﬁcant all-year nonrandom distribution of
onset throughout the year, with peaks in April and June and no correla-
tion with monthly rainfall.
3.2. Crop production
Using publicly available data from governmental and non-govern-
mental sources, we evaluated the possible impact of environmental fac-
tors, speciﬁcally food security [21] and crop harvest patterns [24],during the time of NS onset as reported in our survey questionnaire.
While families resided in IDP camps andwere providedwith emergency
food supplies, local cultivation of food crops was sometimes possible
during their internment. Analysis of the planting and harvest times for
10 essential staple foods showed the peak months (April/June) of re-
ported head nodding onset corresponded to times when planting was
underway or completed for most crops (Fig. 4). The end of the harvest
times for sorghum (August), cassava (August), sweet potato (October)
and maize (November) suggested that stocks would have been low in
April the following year, the month when onset of head nodding ﬁrst
peaked.
Months of reported low crop production by displaced families
(March to July) corresponded to periods when feeding the family re-
portedly was most difﬁcult (Fig. 5). Food storage in IDP camps was
poor and prone towetting and spoilage in the formofmold growth [21].
Fig. 4.Harvest patterns for staple foods in northernUganda. Planting periods (green bars) and harvest periods (yellow bars) for 10 essential staple plant foods in northernUganda showed
an extremely limited number of crops harvested between January and May. Data source: United Nations Food and Agriculture Organization [24].
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3.3.1. Demography and residence
All NS Cases met the consensus deﬁnition for NS except for one sub-
ject who had onset of head nodding (one year-old) outside the deﬁned
age range. NS Cases and CC were similar in age, sex, and family size
(Table 1). Males with NS non-signiﬁcantly predominated over females
with NS. Of the 50 NS Cases, the average age when head nodding in
the child was ﬁrst noted by the caregiver was 7.6 years. NS-affected
families of up to 8members had up to 6 (NS Case+5other NS-affected)
children with Nodding Syndrome.
The child's current body weight showed the strongest association
with NS (est. OR = 0.93; 95% CI: 0.87–0.98 per each additional kg,
p=0.005) and was the only NS-associated demographic characteristic.
Age of the child (p = 0.091), weight at birth (p = 0.865; n = 18Fig. 5. Food shortageswere associatedwith periods of low crop production. Displaced people in
families (dots) during periods of low crop production (diamonds). Data were taken from theWmatched pairs), sex (p= 0.477) and number of people per household
(family size; p = 0.390) were not associated with NS. Both NS and CC
were equally likely to have lived in an IDP camp (p= 0.53), and there
was no correlation between prior IDP residence location and NS.
3.3.2. Dietary history and association with NS
Three food-related variables were signiﬁcantly more frequent for NS
than CC: (a) the family consumed emergency food delivered by the
World Food Programme (est. OR = 4.00; 95% CI: 1.27–17.6, p =
0.016) and, immediately prior to onset of head nodding, (b) the family
used maize, including moldy maize (est. OR = 4.00; 95% CI: 1.00–
26.5, p = 0.50) and (c) used moldy maize for consumption (est.
OR = 4.33; 95% CI: 1.40–18.9, p= 0.009) (Table 2 and Supplementary
Fig. S1) (vide infra). The maize consumed reportedly smelled bad and
induced diarrhea and vomiting. Use of other common items for food,KitgumDistrict reportedmonths duringwhich they encountered difﬁculties feeding their
FP Food Security Report of Ugandan camps for internally displaced persons [21].
Table 1
Demographic characteristics of Cases of Nodding Syndrome (NS) and Community
Controls.
Characteristics NS Cases
Community
Controls p-Value
Total subjects 50 50
Age (years). Mean ± SD (range) 15.6 ± 1.5
(12–18)
15.4 ± 1.8
(12–18)
0.091
Sex (M:F) 1.4:1 1.6:1 0.477
Family size. Mean ± SD 8.3 ± 3.2 7.8 ± 2.7 0.58
Age at onset of head nodding. Mean ± SD 7.6 ± 3.1 − −
Number of other NS Cases in household.
Mean (range)
1.6 (1–5) − −
Table 2
Dietary factors immediately before onset of head nodding in Nodding Syndrome vs. equivalen
Factors N
Dietary importance
Importance of maize in diet 48
# 1 (ref)
# 2
# 3
Importance of sorghum in diet 48
# 1 (ref)
# 2
# 3
Importance of cassava in diet 45
# 1 (ref)
# 2
# 3
Importance of bean in diet 22
# 1 (ref)
# 2/3
Food quality
Quality of maize 47
Quality of cassava 43
Quality of sorghum 47
Quality of cowpeas 17
Quality of bean 21
Foodstuff use
Use of any cassava 50
Use of any bean 50
Use of any cowpeas 50
Use of any pearl millet 50
Use of any sweet potato 50
Use of maize for food 50
Use of moldy maize 50
Use of red sorghum 50
Use of moldy red sorghum 50
Use of white sorghum 50
Use of moldy white sorghum 50
Use of pearl millet 50
Use of moldy pearl millet 50
Use of sweet cassava 50
Use of bitter cassava 50
Use of moldy cassava 50
Local produce
Household grew vegetable 50
Household gathered vegetable 50
Household gathered wild fruits 50
Household gathered wild roots 50
Food supplements
Took vitamin/mineral supplements 49
Ate taboo foods 50
Possibly ate plants while unsupervised by adults 50
Ate sclerotia 50
Ate smut 50
Ate special meals 45
Ate food unﬁt for human consumption 47
Ate deteriorated food 44
Ate emergency food supplies 47
Ate emergency sorghum 32
Ate (pesticide)-painted seeds 47
Signiﬁcant values shown in bold.
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and CC (Table 2).
3.3.3. Medical history and clinical ﬁndings
The only difference between NS and CC in the medical history was a
caregiver's report of acute measles infection prior to onset of NS (est.
OR= 6.00; 95% CI: 1.03–113, p=0.047). Current bodyweight was sig-
niﬁcantly lower in NS vs. CC. (Table 3).
NS children were under treatment with sodium valproate, and ﬁve
subjects reported no head nodding at the time of examination. Six NS
Cases reportedly had a history (age unknown) of convulsions associated
with fever years before onset of head nodding. Clinical manifestationst time period for Community Controls. Food quality was scored on a Likert scale of 1–5.
OR (95% CI) χ2 (df) p-Value
χ2 (2) = 0.51
1.0
0.60 (0.123–2.44) 0.777
1.00 (0.120–8.33)
χ2 (2) = 2.00 0.368
1.00
0.57 (0.228–1.33)
0.29 (0.012 to 3.44)
χ2 (2) = 0.06 0.971
1.00
0.91 (0.098–8.46)
1.03 (0.122–8.70)
χ2 (1) = 2.94 0.086
1.0
3.50 (0.846–23.5)
1.25 (0.834–1.93) χ2 (1) = 1.15 0.284
1.58 (0.890–3.20) χ2 (1) = 2.38 0.123
1.08 (0.755–1.54) χ2 (1) = 0.16 0.686
0.96 (0.522–1.73) χ2 (1) = 0.02 0.882
0.81 (0.41–1. 61) χ2 (1) = 0.36 0.548
1.5 (0.259–11.4) χ2 (1) = 0.20 0.654
1.09 (0.478–2.51) χ2 (1) = 0.04 0.835
0.83 (0.36–1.93) χ2 (1) = 0.18 0.670
1.22 (0.506–3.03) χ2 (1) = 0.20 0.654
0.60 (0.204–1.62) χ2 (1) = 1.01 0.315
4.00 (1.002–26.5) χ2 (1) = 3.85 0.050
4.33 (1.397–18.9) χ2 (1) = 6.74 0.009
1.75 (0.529–6.68) χ2 (1) = 0.83 0.363
2.20 (0.800–6.98) χ2 (1) = 2.31 0.129
1.80 (0.831–3.90) χ2 (1) = 2.32 0.128
1.90 (0.902–4.25) χ2 (1) = 2.84 0.092
1.71 (0.690–4.61) χ2 (1) = 1.33 0.249
2.00 (0.777–5.74) χ2 (1) = 2.04 0.153
2.00(0.630–7.49) χ2 (1) = 1.36 0.244
1.00(0.534–5.29) χ2 (1) = 0 1
1.29 (0.479–3.60) χ2 (1) = 0.25 0.617
2.50(0.539–17.4) χ2 (1) = 1.33 0.249
1.33(0.464–4.05) χ2 (1) = 0.29 0.592
1.00(0.342–2.92) χ2 (1) = 0.00 1
1.29(0.479–3.60) χ2 (1) = 0.25 0.617
1.50(0.621–3.83) χ2 (1) = 0.81 0.370
2.00(0.390–14.4) χ2 (1) = 0.68 0.410
0.93 (0.431–1.99) χ2 (1) = 0.04 0.847
1.50(0.541–4.47) χ2 (1) = 0.60 0.437
0.36(0.101–1.06) χ2 (1) = 3.40 0.065
2.60 (0.981–8.10) χ2 (1) = 3.68 0.055
1.00(0.459–2.18) χ2 (1) = 0.00 1.00
1.33(0.464–4.05) χ2 (1) = 0.29 0.592
4.00 (1.271–17.6) χ2 (1) = 5.78 0.016
2.40(0.890–7.54) χ2 (1) = 2.97 0.085
2.33(0.936–6.59) χ2 (1) = 3.29 0.070
Table 3
Association between anthropomorphic data and health status in NS vs. CC.
N
Odds ratio
(95% CI) χ2(df) p-Value
Birth weight 18 0.92 (0.332–2.47) χ2 (1) = 0.03 0.865
Current body weight 49 0.93 (0.871–0.978) χ2 (1) = 8.04 0.005
Sex 50 1.67 (0.409–8.12) χ2 (1) = 0.51 0.477
Age 50 2.00 (0.909–7.09) χ2 (1) = 2.85 0.091
Number of people in household 50 1.06 (0.927–1.23) χ2 (1) = 0.74 0.390
Hx of prior illness 50 1.83 (0.698–5.32) χ2 (1) = 1.49 0.222
Hx. of urinary infection 50 0.71 (0.308–1.60) χ2 (1) = 0.67 0.413
Hx. of diarrhea 50 0.80 (0.305–2.03) χ2 (1) = 0.22 0.637
Malaria 50 0.93 (0.431–1.99) χ2 (1) = 0.04 0.847
Hx. of ear/nose/throat infection 50 0.25 (0.013–1.69) χ2 (1) = 1.93 0.165
Hx. of measles 50 6.00 (1.025–113) χ2 (1) = 3.96 0.047
Hx. of chicken pox 50 0.50 (0.023–5.22) χ2 (1) = 0.34 0.560
Hx. of any other illness 50 1.50 (0.541–4.47) χ2 (1) = 0.60 0.437
Hx. of oral lesions 50 0.50 (0.023–5.22) χ2 (1) = 0.34 0.560
Received deworming 40 0.83 (0.352–1.93) χ2 (1) = 0.18 0.670
Received Ivermectin 40 1.00 (0.390–2.56) χ2 (1) = 0.00 1.00
Prior residence in IDP camp 50 0.67 (0.170–2.33) χ2 (1) = 0.40 0.526
Signiﬁcant values shown in bold.
Table 4
Prevalence of clinical and behavioral features among NS Cases.
Clinical and behavioral features N (%)
Clinical signs:
Fixed gaze/staring 26 (52%)
Uncoordinated limb movements 17 (34%)
Drooling saliva (mouth open) 25 (50%)
Disorientation 27 (54%)
Episodes of loss of consciousness 19 (38%)
Localized facial or limb movements 4 (8%)
Generalized convulsions 18 (36%)
Perceptual disturbances (before/after ﬁts) 27 (54%)
Aggressive behavior 24 (48%)
Wandering 14 (28%)
Sleep pattern:
Normal sleep 13 (26%)
Lacks sleep 5 (10%)
Excessive sleep 23 (46%)
Bad dreams 9 (18%)
Change in appetite:
Normal appetite 18 (36%)
Reduced appetite 14 (28%)
Increased appetite 18 (36%)
Emotion (most of the time):
Feels normal 17 (34%)
Feels sad 22 (44%)
Feels anxious/fearful 6 (12%)
Feels excited 5 (10%)
Predominant thoughts/preoccupations:
Normal thoughts 22 (44%)
Worried 26 (52%)
Thoughts of dying/self-harm 2 (4%)
Social interaction:
Good 26 (52%)
Poor/no social interaction 24 (48%)
Functional deﬁcits and injuries
Mental impairment 30 (61%)
Visual impairment 2 (4%)
Gait ataxia 5 (10%)
Inability to walk 1 (2%)
Feeding and swallowing difﬁculties 1 (2%)
Behavioral difﬁculties 10 (20%)
Cognitive and learning difﬁculties 32 (64%)
Speech difﬁculties 11 (22%)
Difﬁculty with activities of daily living 11 (22%)
Injuries and burns 5 (10%)
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terns (74%), including excessive sleep (46%), bad dreams (18%), and
lack of sleep (10%); mental impairment (61%); disorientation (54%);
ﬁxed gaze/staring (52%); drooling saliva (50%); aggressive behavior
(48%); emotional problems (56%); episodes of loss of unconsciousness
(38%); uncoordinated limb movements (34%); wandering (28%); be-
havioral disability (20%); and localized facial or limb movements (8%).
Furthermore, caregivers reported cognitive impairment (60%), ataxia
(10%), visual difﬁculty (4%) and inability to walk (2%) among NS Cases
(Table 4).
At the time of examination, subject history of reported treatment
with ivermectin, antimalarials and deworming medication was similar
in NS and CC. Reported vaccination was also similar (mostly N90%) for
poliomyelitis, tetanus, diphtheria, pertussis and tetanus (DPT), and
measles (Table 5). Whether the vaccination was recent or otherwise
was not determined.4. Discussion
4.1. Main ﬁndings
Study results show that between 2000 and 2013, the community of
Tumangu village, Kitgum District, northern Uganda, experienced a
semi-bimodal NS epidemic, with apparent peaks in 2003 and 2008
and all-year mean monthly maxima in April and June, the latter corre-
sponding to a nadir in production of crops used as staple foodstuffs
and peak difﬁculty in feeding families. Immediately prior to the ﬁrst ap-
pearance of head nodding, there was a greater nutritional dependence
by NS vs. CC on emergency food supplies, including moldy plant prod-
ucts, particularlymoldymaize. NS Caseswere reported to have a normal
birthweight but, on examination inMarch 2014, exhibited a lower body
weight thanhealthy Community Controls perhaps arising frompoor nu-
trition and/or social neglect. On average, a child with NS had more than
one and sometimes multiple NS-affected siblings suggestive of familial
stressors, such as nutritional and/or infection.
Caregiver report of prior measles illness was signiﬁcantly higher in
children with NS vs. CC, although 2014-reported immunization rates
for measles and other infectious diseases were similar (but somewhat
lower in NS). These children were all born (dob: 1996–2002) during
the conﬂict period (1996–2006/8), when food variety and quality
were poor, measles immunization was absent (until 2002/3) and, con-
sequently, acute measles infection rates were very high (1998–2002,
vide infra). Immunization for infectious diseases must have occurred
during or after the tail end of the conﬂict (circa 2006). Below, we exam-
ine the hypothesis that the etiology of NS arises from an interaction be-
tween early-age measles infection and malnutrition.Table 5
2014 vaccination status, nutritional supplements, and anti-parasitic medications.
Group Proportion received
Polio NS Cases 93%
Community Controls 96%
Tetanus NS Cases 51%
Community Controls 59%
Measles NS Cases 95%
Community Controls 98%
DTP NS Cases 95%
Community Controls 98%
Antimalarial NS Cases 24%
Community Controls 20%
Ivermectin NS Cases 76%
Community Controls 77%
Vitamin A NS Cases 76%
Community Controls 88%
Deworming NS Cases 68%
Community Controls 75%
Fig. 6.Measles epidemic (Uganda) preceded the NS epidemic (Tumangu, northern Uganda). Onset peak of NS (right-side trace) from 2003 to 2008 followed the onset peak of reported
measles incidence in Uganda (left-side trace) from 1998 to 2002. World Health Organization data show that measles cases in Uganda rose dramatically in 1997 through 2003
(N40,000 cases/year) when, in 2003, the United Nations called for a warfare truce to permit measles vaccination in northern Uganda, with rates dropping precipitously countrywide by
2004. Data source: WHO Vaccine Preventable Diseases: Monitoring System. 2014 Global Summary [22]. Doctors without Borders also carried out a measles-vaccination campaign
(exact location unstated) in September 2004 covering 20,000 children under the age of ﬁve [23]. NS incidence data were taken from March 2014 Tumangu survey.
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Age-matched NS and CC subjects showed a single signiﬁcant differ-
ence in medical history, namely a caregiver's report of prior measles in-
fection OR 6.0 (95% CI 1.025–113, p = 0.047). Five years earlier
(December 2009) in west Kitgum, a CDC-led case-control study of NS
[7] comprising 49 cases (55% males, mean age 11.6 years) unmatched
for age to 49 village controls (44% males, mean age 8.5 years,
p N 0.001), found that self-reported measles was also signiﬁcantly
higher among NS Cases (OR 4.0, CI 1.1–14.2); however, the association
with measles was lost when subjects were matched for age post hoc
[7].5
Given that two independent studies of NS in Kitgum District have
identiﬁed a case association with prior measles infection, it is impera-
tive to consider the possibility that NS is a type of post-measles brain
disorder of which several are known. Measles is endemic in Uganda,
more common in children under age 5, with higher mortality rates
among immunocompromised and malnourished subjects. Measles is a
major cause of infant death in populations lacking immunization. In
Uganda, the acute measles incidence was very high between 1998
(~45,000 cases) and 2002 (~50,000 cases), dropping precipitously
thereafter to baseline levels, with small elevations in 2006 and 2013
(Fig. 6). The geographical distribution of these cases is uncertain, but
themarked reduction of cases from 2002 onward accords with the vac-
cination campaign undertaken in northern Uganda towards the cessa-
tion of regional hostilities. By 2011, regional measles vaccination
coverage across Acholiland was reported to be 90% (2/3rd of whom
held vaccination cards) among 9- to 59-month-old children, above the
national target of 85% [30]. This accords with present data showing sim-
ilarly high reported vaccination percentages for NS (95%) and CC (98%).
However, for future studies, it should be noted that a survey conducted
by the UgandaMinistry of Health andWorld Health Organization in the
ﬁrst 6 months of 2005 revealed that a considerable proportion of5 Multiplex Polymer Chain Reaction (PCR) analyses for 19 families of viruses, plusmea-
sles virus, performed on cerebrospinal ﬂuid (CSF) of 16 NS cases and zero controls, was re-
portedly negative across the board [7,3]. Since CSF samples of 14 tested cases with “a high
clinical likelihood of headnodding” and no controlswere also negative for protein (normal
value: 14–45 mg/dL) and low in glucose (7–1 vs. a normal value of 40–70 g/dL), the bio-
logical integrity of the CDC-study samples may have been sub-optimal. Because the study
site in Kitgum District is in a remote location, lacks dry ice and refrigerated transport, it is
challenging tomaintain biological samples in optimum condition required formeasles an-
tibody assays according to CDC guidelines [29]. Samples collected in the CDC study were
analyzed in Atlanta, GA, approximately 30 h travel time from the collection site. While
wewouldhave faced similar technical challenges, our study designdid not include the col-
lection of cerebrospinal ﬂuid or blood for viral analyses.children in Kitgum District (34.5%) and Pader District (19.9%), two
heavily NS-affected populations of Acholiland, had no written evidence
of measles vaccination [31].
4.3. Nodding Syndrome: a post-measles brain infection?
4.3.1. Comparative epidemiology of measles-NS and measles-SSPE
Among those who survive measles infection as infants, ~3 of every
10 cases experience complications that may include the tardive brain
disorder subacute sclerosing panencephalitis (SSPE) [32]. SSPE is a
rare but well studied progressive ‘slow viral’ disease caused by persis-
tent brain infection with defective measles virions that most often sur-
faces clinically 6–8 years after an acutemeasles illness [33]. SSPE usually
affects children aged 5–13 years, sometimes involvingmales more than
females. By comparison, themean age of onset of NS in Tumangu village
was 7.6±3.1 years, and both this and the preceding CDC study included
a preponderance (55%) of males among the randomly selected NS Cases
[7]. Thus, NS and SSPE affect children of similar proportionate sex and
age.
The incidence of NS in Tumangu peaked 5–6 years (2003–2008)
after the peak incidence ofmeasles (1998–2002), and the post-immuni-
zation drop to near zero cases of measles (2004) preceded by 7 years a
precipitous drop in cases of NS (Fig. 6). By comparison, themean period
from acute measles infection to SSPE onset (latency) is 4–10 years [34–
36]. In Israel in the 1960–1970s, peaks for the incidence of measles and
SSPE were separated by 7–9 years. Measles vaccination begun in 1967
resulted in a dramatic reduction of SSPE and increased onset age from
7 years in 1966 to 17 years in 1986 [35,36]. Subsequently, in Germany,
the incidence peaks for cases of childhood (under 5 years) measles
(1993–2001) and SSPE (2002–2009) were separated by 8–9 years [36,
37]. Taken in concert, therefore, the latency period between acute mea-
sles infection and SSPEmatches the temporal separation between peaks
of measles and NS in Uganda.
4.3.2. Clinical features of NS vs. SSPE
There are numerous similarities in the clinical features of patients
with NS and SSPE. The clinical course of NS in Ugandan children has
been described [38], and later stages have been documented in
longstanding Tanzanian patients [9]. Importantly, one third (11/33) of
the latter subjects (and 7/50 in the present study) had a history of fe-
brile seizures in infancy consistentwith (but not speciﬁc for) acutemea-
sles infection [4]. Both NS and SSPE have an insidious afebrile onset,
with behavioral changes (notably irritability) and intellectual deteriora-
tion, followed by myoclonus, typically beginning with the head [5,8,33,
39,40]. Unpublished data from the World Health Organization (WHO)
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cases was usually head nodding (53/87), half of which evolved to head
nodding and seizures, while the balance either began and continued
with both (7/87), or began with seizures (27/87) and later added
head nodding (6/27) (K. Vandermaele et al., unpublished data, 2002).
Similarly, SSPE may be present with generalized seizures [41–43]. Par-
tial seizures and generalized tonic-clonic seizures occur in both
diseases.
Head nodding corresponds with atonic seizures in African children
in both NS [2] and SSPE [44]. Detailed description of myoclonic head
nods in a black female African child with measles virus D3 serotype-as-
sociated SSPE is described by Vardas and associates [45]. Canadian chil-
dren with head drops early in SSPE are described and illustrated by
Campbell and colleagues [35]. Head nodding may occur on awakening
and is exacerbated by excitement in SSPE [33,46], and triggered by the
sight of food, eating and cold in NS [8]. This suggests the brain is in a
“proconvulsive” state in both NS and SSPE. Signs of, sleepiness, stupor,
catatonia,muscleweakness, speech disturbance and sudden falls are re-
ported in both SSPE and NS [33,38,47–49]. With the advance of SSPE,
myoclonus may decrease or disappear, spasticity with pyramidal and
extrapyramidal signs becomes apparent, and a few develop ataxia, dys-
tonia and dyskinesia [33]. Similarly, ataxia, hyperreﬂexia and parkinso-
nian signs are described in longstanding cases of NS [4]. Unusually cold
lower extremities have been reported in Sudanese and Ugandan chil-
dren with NS [5,38] while, in advanced stages of SSPE, loss of thermo-
regulation causes marked core temperature ﬂuctuations [33].
Progressive cognitive decline leading to dementia and mutism is de-
scribed in both disorders [33,38,48]. Ocular and visual manifestations,
including papilledema, optic atrophy and choreoretinitis, cortical blind-
ness) affect a minority of patients with SSPE [33], mostly those with
adult-onset brain disease [49]. Formal ophthalmological assessment of
children with NS is awaited, the results of which would have to be con-
sidered in relation to the potential visual effects (River Blindness) of in-
fectionwithO. volvulus. TwoNS children in the present study reportedly
had visual difﬁculty.
Magnetic resonance imaging (MRI) of brains in SSPE and NS also
show overlap. Whereas many studies have documented SSPE sequen-
tially, fewMRI images are available for NS. The brain may be unremark-
able initially but can progress to severe atrophy in both conditions [38,
50]. In SSPE, abnormalities reﬂecting loss of myelin aremore commonly
seen bilaterally or asymmetrically in the occipital subcortical white
matter than in the frontal region. Jagtap and Kambale [51] found gray
as well as white matter changes in the parieto-occipital area, followed
by involvement of the fronto-parietal region. By comparison, in NS
brains with generalized cortical atrophy, Idro and colleagues [38]
noted “a suggestion of more atrophy in the occipital lobes or the
parieto-occipital regions than anteriorly”. Basal ganglia, thalamus, cere-
bellumand brainstemare less commonly involved in SSPE [52,53]. Cere-
bral and cerebellar atrophy has been noted in NS [38,54].
4.3.3. Survival period and other features of NS vs. SSPE
NS is a progressive epileptic encephalopathywhich, when untreated
in the setting ofwartime then-southern Sudan,was reported by local in-
formants to have a ~3-year downhill course and fatal outcome (P. Spen-
cer, unreported data). Adequate nutrition and treatment with
anticonvulsants (valproic acid) greatly reduces seizure activity, mark-
edly improves health, but fatalities occur and life expectancy of treated
NS patients is unknown [1]. Some Tanzanian patients survived for 1–
3 decades (mean=12.6 years) after onset of head nodding [4]. By com-
parison, SSPE patients often have a rapid downhill course to death (1–
3 years), with a fatal prognosis in 95% of patients. However, less aggres-
sive forms are recognized [55], and the course of SSPE is sometimes var-
iable and unpredictable [56]. Remission or halting of disease
progression occurs spontaneously in 5% of SSPE cases. Remission may
be temporary, lasting weeks to years [57,58]. A disease course beyond
5 years is unusual but a few SSPE cases survive for up to 12–14 years[59,60]. A 17 year-old Indian female who developed SSPE and
underwent progressive neurological deterioration experienced a sub-
stantial spontaneous clinical and electroencephalographic remission
that was maintained for at least 8 years [61]. In Colombia, two patients
with SSPE returned to almost normal intellectual function after having a
typical clinical course and electroencephalographic picture, and after
being in a vegetative state for several weeks. Another patient recovered
from a vegetative state and was left with moderate mental retardation
and minimal motor sequelae. A further seven patients survived in a se-
vere state of decortication without further progression [62]. In sum, the
temporal course of SSPE and NS overlaps.
The neuropathology of NS has yet to be described but crystalline in-
clusions of unknown signiﬁcance have been described by CDC (letter
from Dr. Wun-Ju Shieh to Ruth Aceng, Uganda Director-General of
Health Services) in histological sections of the pons (viewed using po-
larized light) of autopsied brains of 5 NS children aged 12–15 years
[18,63]. The neuropathology of SSPE is stage-dependent (mild inﬂam-
mation to gross atrophy) and characterized by measles antibody-posi-
tive intranuclear and intracytoplasmic eosinophilic inclusion bodies
[64], and tau- and ubiquitin-positive neuroﬁbrillary tangles [65], with
typical involvement of the brainstem and elsewhere [33,49]. By trans-
mission electron microscopy, the eosinophilic inclusions correspond to
paracrystalline arrays of measles nucleocapsids [66]. There is an urgent
need to determine if the crystalline inclusions of NS correspond to viral
nucleocapsid inclusions.
While the foregoing epidemiological, clinical and imaging observa-
tions raise the possibility that NS is a post-measles SSPE-like disorder,
demonstration of this putative association requires evidence of measles
antibody in cerebrospinal ﬂuid, a compatible electroencephalographic
(EEG) picture (which is stage-dependent in SSPE), and immunocyto-
chemical demonstration of paracrystalline neuronal and glial cell inclu-
sions positive for the measles virus genome. It is noteworthy that
oligoclonal bands in cerebrospinal ﬂuid, typical of CNS infectious dis-
eases including SSPE [67], have been reported in NS [68]. The few EEG
observations in NS have demonstrated severely abnormal background
activity with interictal diffuse slowing, as well as spike-and-wave and
polyspike and wave epileptiform discharges [3,54,69,70].
4.4. Trigger and seasonality of Nodding Syndrome
The differential monthly/seasonal timing of reported onset of head
nodding showed all-yearmean peaks in April/Junewhen local crop pro-
duction was at its lowest (March to July) and food shortage at its peak
(June). For people crowded in IDP camps of Kitgum District, there was
a signiﬁcant association between NS and family use of emergency food
supplies (OR 4.0 CI 1.29–12.40, p=0.016) and poor quality food imme-
diately prior to the ﬁrst sign of head nodding. Might such factors be re-
lated to reactivation of a putative latent brain measles virus? The
interplay between the measles virus and human hosts is well studied
at the population level [71] but the trigger for SSPE is unknown [72].
Measles epidemics show regular patterns that are modiﬁed by human
activity, such as the seasonal crowding of children in primary schools
[73]. Illustrative of seasonal differences of measles [74], April and May
are the peak months for measles (H1a genotype) in Shanghai, China
[75]. In the context of many less developed countries, general seasonal
drivers, including agricultural cycle and associated droughts and fam-
ines, are likely to play a more signiﬁcant role [76]. Perhaps these obser-
vations are relevant not only to the timing of acute infectious measles
but also to the reemergence of latent measles infection in the form of
SSPE and, perhaps, NS.
Howmeasles virus in brain is reactivated to trigger progressive neu-
rological disease years after primarymeasles infection is unknown [77].
The question is broadly relevant to neurotropic viruses, including those
of the herpes family. Exposure to certain chlorinated solvents has been
proposed to activate latent ganglionic Herpes simplex virus and thereby
trigger trigeminal neuralgia [78]. Among herpes labialis-prone African
Fig. 7. Cases of measles in Uganda, Tanzania, and Sudan 1980–2013. Number of reported cases in 1980: b20,000 (Uganda), b60,000 (Sudan) and N60,000 (Tanzania). Data from country-
speciﬁc WHO Vaccine-preventable Diseases Monitoring System [25–27].
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ducing infections (malaria), stress and fatigue [79]. In the case of herpes
virus 4 (Epstein Barr virus, EBV), physical and psychological stressors
associated with spaceﬂight resulted in decreased virus-speciﬁc T-cell
immunity and reactivation of EBV [80]. Additionally, the mycotoxin af-
latoxin B1 reactivates the EBV cycle and triggers pro-carcinogenic
mechanisms that culminate in Burkitt's lymphoma [81]. Aﬂatoxin and
other immunosuppressivemycotoxins contaminatemaize in east Africa
[82], exposure to aﬂatoxin is ubiquitous among rural Ugandans [83],
and the present study found NS case association with moldy maize at
onset of head nodding. Thus, it is plausible that a latent mutant measles
virus sequestered in the brains of future NS Cases could have been
reactivated by nutritional deprivation and/or mycotoxin-induced im-
munosuppression. Another risk factor associated with NS in this popu-
lation is stress arising from violent wartime activities [7,9,84].4.5. Measles and NS in east Africa
4.5.1. South Sudan
World Health Organization (WHO) measles incidence data for the
NS-affected countries of Uganda [25], Tanzania [26] and Sudan [27]
are shown in Fig. 7. In war-torn Sudan, where epidemic NS preceded
that in northern Uganda by ~10 years, measles immunization was ex-
ceptionally low in the 1990s [85,86] and immunization supplies
dropped drastically during the period of conﬂict. Reported cases ofmea-
sles peaked in 1982 (~70,000 cases), 1985 (~70,000 cases) and 1991
(~30,000 cases) before dropping to low levels (b10,000 cases per
annum) from 1992 to 2013. In then-southern Sudan, recorded cases of
measles dropped from nearly 2000 to below 100 per annum between
2006–2010 and, during this period, infant and under-ﬁve mortality
rates decreased from 102 to 84 and 135 to 106 per 100 live births, re-
spectively [27,28]. The ﬁrst cases of NS were reported in 1991, 6–
9 years after peak incidence of measles cases countrywide, the timing
of which ﬁts with the appearance of a post-measles brain disorder
akin to SSPE.66 However, in 2002, two of us (J.T., P.S.) participated in aWHOoutbreak investigation of
Nodding Syndrome in southern Sudan that found a signiﬁcant inverse relationship be-
tween a reported history of measles andNS [5,8]. We cannot explain this result other than
to note thatmeasles infection of infants b age 1 year (the age for high risk for post-measles
brain complications)may go unrecognized [8]. Possible differences inmeasles vaccination
history were also not obtained in the southern Sudan study [5].The most striking yet puzzling ﬁnding of theWHO-led 2002 NS dis-
ease outbreak investigation in then-southern Sudan was the high prev-
alence of head nodding in the sessile Moru subsistence farmers and the
complete absence of the disorder in itinerant Dinka pastoralists. An ini-
tial hypothesis focused on nutrition [87], the Dinka having access to
milk, blood and meat, and their practice of prolonged infant nursing,
while the Moru generally lacked livestock, hunted and gathered wild
plants seasonally, and cultivated rain-fed plants grown in communal
gardens which, during periods of internal displacement, likely suffered
in quality, including mold infestation [8]. In the present study in neigh-
boring northern Uganda, we found a signiﬁcant temporal relationship
between onset of head nodding and family dependence on moldy
plant products, in particular moldy maize (Zea mays) which, in Uganda
and other sub-Saharan countries, contains immunosuppressive aﬂatox-
in and fumonisin mycotoxins [88–90]. While these agents might have a
role in the clinical expression of NS (vide supra), it has also long been
recognized that malnutrition-induced immunocompromise increases
susceptibility to infectious agents, including measles paramyxovirus
[91].
4.5.2. Paramyxoviridae and NS susceptibility in east Africa
4.5.2.1. Measles and related viruses.Measles in primates, distemper in ca-
nines and rinderpest in ruminants, are caused by closely related
enveloped paramyxoviruses of the genus Morbillivirus. These viruses
are highly infective, spread via the respiratory route, induce profound
immune suppression, and cause large disease outbreaks with highmor-
tality. Cross-immunity among susceptible species is known; for exam-
ple, dogs that feed on rinderpest-infected meat can acquire immunity
against rinderpest virus and canine distemper virus [92] and measles
vaccination offers protection of dogs from canine distemper [93]. With-
in the Morbillivirus genus, measles virus is hypothesized thousands of
years ago to have crossed the species barrier from cattle to primates/
humans [94].
4.5.2.2. South Sudan. Rinderpest was endemic in then-southern Sudan
during the time of the 2002WHO-ledNS-outbreak study. Animal health
services before the war and in the period of peace (1972–1983) were
not effective, such that endemic rinderpest was not controlled. Vaccina-
tion campaigns (1992–2001) reduced the number of rinderpest out-
breaks from 12 in 1993 to 2 in 1998, with eradication by 2005 [95,96].
Thus, prior to the 1991 outbreak of NS, and for many years thereafter,
there was a high probability the Dinka (unlike the Moru) would have
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virus. Since the rinderpest virus is very closely related to the human
measles virus, theDinka could have acquired cross immunity tomeasles
in the sameway that British physician-scientist Edward Jenner, FRS (the
18th Century “Father of Immunology”) noted that milkmaids who ac-
quired cowpox (a mild disease) developed immunity to smallpox [97].
If the Dinka acquired protection from measles virus, and NS is a post-
measles disorder, this would explain why Dinka children were spared
NS at the time of the WHO-led disease investigation in 2002. However,
rinderpest-acquired protection from measles would be expected to de-
cline and disappear (with rinderpest eradication) by 2005; thereafter,
newborn children of Dinka families would be at risk for measles infec-
tion and, thus putatively, for NS. In accord with this point, living cases
of NS among Dinka people were reported at the 2nd International Con-
ference on Nodding Syndrome held in Gulu in July 2015 [1].
4.5.2.3. Uganda. A 1990–98 survey of rinderpest identiﬁed the northeast
of Uganda as a high-risk regionwith low seroprevalence. Risk factors for
outbreaks of rinderpest included cattle raids [98] that, during the period
of civil conﬂict, were widely practiced in Acholiland by the LRA. The
resulting depletion of non-LRA members of the population (the large
majority) from potential contact with cattle, especially during periods
of internal displacement, would have excluded exposure to rinderpest
virus and possible acquisition of cross-immunity to measles. By con-
trast, LRA-related children, none of whom is known to have developed
NS, would have had a much higher potential exposure to cattle, includ-
ing those harboring or expressing the rinderpest virus. Only one of our
study members, an 18-year-old female CC, reported spending time
with the LRA.
4.5.2.4. Tanzania. There is little informationwithwhich to assess risk fac-
tors for NS among the isolated Pogoro people of theMahenge highlands
in Tanzania [3]. In World War 1, Mahenge was held as a military garri-
son by Germany, which had zero tolerance for cattle infected by rinder-
pest [99]. Head nodding in this populationwas reported as early as 1934
[4], with the ﬁrst clinical descriptions in the 1960s [2,3]. At this time, the
Wapogoro were subsistence farmers who cultivated maize and millet,
lacked food storage systems, and did not keep livestock [99]. Subject
to periodic famine, theywere plagued by a combination ofmalnutrition,
avitaminosis, protein deﬁciency, severe parasitic (includingOV) infesta-
tion, anemia and epilepsy [100]. Outbreaks of measles in the vicinity are
also recorded [101]. By the turn of the century, only 65% had received
measles vaccine by age one year [102], the age of acute infection that
carries the maximum risk for post-measles SSPE. In sum, therefore,
the NS-susceptible Pogoro people of Tanzania show parallels with the
NS-susceptible Moru (vide supra) given their probable common lack
of exposure to rinderpest-prone ruminants, susceptibility to measles,
and dependence on rain-fed plants subject to spoilage and fungal
contamination.
4.6. Nodding Syndrome and Onchocerciasis
An alternative etiologic hypothesis for NS focuses on the signiﬁcant
case-association with Onchocerca volvulus (OV), a nematode and cause
onchocerciasis, some cases of which develop visual deﬁcits (i.e. River
Blindness) [7,103]. While the current study did not evaluate this hy-
pothesis, two of the authors (P.S, J.T.) participated in the 2002 WHO-
led case-control study of NS in then-southern Sudan that ﬁrst reported
the NS-OV association [5,8]. The association was later found in the 2009
CDC study of NS in west Kitgum District [7]. OV is also prevalent in the
longstanding focus of NS in Mahenge Tanzania [104] and speculation
on the potential etiologic role in NS of infection with OV and/or the OV
symbiotic bacterium Wolbachia, continues [18,105]. However, the OV
hypothesis suffers from (a) the presence of active OV-related disease
in NS-free regions of sub-Sahara, Central and South America, and in
many neurologically normal controls used in case-control studies, (b)the absence of OV infection in a small percentage of NS Cases in Uganda
[15,68], and (c) the negative results of independent PCR analyses for OV
in the CSF of Sudanese and Tanzanian childrenwith NS. Neurological ill-
ness (vertigo, headache and vomiting) in onchocerciasis arises from the
side effects of anti-ﬁlarial drug treatment targeted at microﬁlariae in ce-
rebrospinal ﬂuid [5,106] which itself does not offer protection from
head nodding. Additionally, the peaks of head nodding onset in April
and June reported here donot correlatewith seasonal human ‘biting’ ac-
tivity of OV-infective black ﬂies in nearby northeastern Uganda [105,
107].
We note that acute measles infection severely suppresses the im-
mune system for 2–3 years [108], thereby increasing the risk for persis-
tent all-cause opportunistic infection [108–110], such as the
establishment of persistent OV infection. While the dermatological fea-
tures of OV infection often contribute to the clinical picture in NS [5], we
interpret Onchocerca volvulus to be a bystander in Nodding Syndrome,
not the cause of this devastating, possibly measles-associated brain dis-
ease. Resolving this issue is important because planned treatment trials
of Ugandan children are based on an hypothesis that NS is a
neuroinﬂammatory disorder induced by OV or Wolbachia antibodies
cross-reacting with host neuron surface proteins [18]. It should be
noted there aremany causes of neuroinﬂammatory disorders, including
post-measles SSPE, a progressive inﬂammatory brain disease.
4.7. Study limitations
1. Recall bias. The case-control study results heavily depend on the ac-
curate recall of caregivers. All caregivers were livingwith the NS case
at the time of head-nodding onset. All CC lived in householdswith no
NS case. OneNS had no CC. Other household cases of NSwere report-
ed by the caregiver and conﬁrmed in government case records held
by the Village Health Team Leader.
2. Accuracy of the reportedmonth of onset of head nodding. Since head
nodding may be preceded by a prodromal period [6], the actual
month of clinical onset of NS may have preceded the reported date
of disease (head nodding) onset.
3. Duration, dosage and currency of treatment of NS Cases with anti-
seizure medication were not determined. Valproic acid is usually
well tolerated but serious complications (including
hyperammonemic encephalopathy) may occur [111] and, if present,
would have affected reported clinical signs.
4. This study was designed as an exploratory effort to generate testable
etiologic hypotheses, which could possibly have led to false-positive
associations in the absence of adequate statistical power.4.8. Study strengths
This is one of the few controlled studies to evaluate the etiology of a
neglected epidemic of a potentially fatal brain disease that places hun-
dreds of thousands of individuals in Sub-Saharan Africa at-risk. The
study was conducted in the community and the villages affected by
NS; transportation to and from the village study site was provided for
all the subjects participating in the study. This decreased the selection
bias associated with differential participation of individuals with in-
creased disabilities due to a higher burden of NS. This is the ﬁrst study
of NS in Uganda that evaluated the diet of subjects. Use of a structured
questionnaire decreased the ascertainment bias of food and nutritional
exposures.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jns.2016.08.023.
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